Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3066% above fair value
$8.30−0.26 (-3.04%)
Close on Nov 13, 2026Market cap $180.76MP/E –Yield –
Alpha Cognition ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Alpha Cognition's ebitda for the twelve months ending Sep 30, 2026 was -$29.39M. For fiscal 2025 it was -$22.60M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.60M | – |
| FY2024 | Dec 31, 2024 | -$11.93M | – |
| FY2023 | Dec 31, 2023 | -$9.85M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.31M | – |
| Q2 FY2026 | Jun 30, 2026 | -$7.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.07M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.36M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.44M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.67M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.40M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.39M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.40M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.74M | – |
See a number that looks wrong?